Earnings
Twist Bioscience (TWST) Q4: Mixed Results With Solid Revenue and Softer EPS
Twist Bioscience posted Q4 revenue of $99 million, beating estimates but missing on EPS at -$0.45.
Total Stories
2,511
News
stocks
Section
stocks
Market Analysis
Why Anavex (AVXL) Is Down 50% Today: EMA Rejects Alzheimer’s Drug Progress
Anavex stock plunged 50% in premarket trading after European regulators issued a negative vote on its Alzheimer’s drug blarcamesine.
Earnings
Legence (LGN) Delivers Q3 Revenue Beat Despite EPS Miss
Legence Corp. posted Q3 2025 revenue of $708 million, up 26% year-over-year and above expectations, and issued upbeat guidance for Q4 and 2026.
Market Analysis
Tesla Drops After Fire-Risk Recall of 10,500 Powerwall 2 Units
Tesla shares dipped in premarket after the company recalled 10,500 Powerwall 2 units over overheating issues tied to faulty battery cells.
Market Analysis
Bitfarms Drops After Missing Q3 Estimates and Announcing AI Shift
Bitfarms slid 13% after missing Q3 EPS and revenue targets and announcing a shift toward AI infrastructure at its Washington site.
Market Analysis
Why Is Mersana (MRSN) Up 200% in Premarket? Day One Biopharma Agrees to $25/Share Buyout
Mersana stock soared 200% premarket after Day One Biopharma agreed to buy the company for $25 per share plus potential milestone payments.
Earnings
Sally Beauty (SBH) Delivers Better-Than-Expected Q4 Performance
Sally Beauty posted Q4 2025 EPS of $0.55 and revenue of $947 million, both above expectations, and expects steady growth in fiscal 2026.
Earnings
Disney (DIS) Beats Q4 EPS but Falls Short on Revenue
Disney reported Q4 EPS of $1.11 alongside $22.5 billion in revenue, topping profit expectations but falling short on sales, with growth expected in 2026.
Earnings
Spectrum Brands Holdings (SPB) Reports Mixed Q4 2025 Results
Spectrum Brands delivered Q4 EPS of $2.61 even as sales fell 5.2% and sees steady growth ahead in 2026, led by Pet Care and Home &…
Market Analysis
IBM Rises After Showcasing Next-Gen Quantum Chip to Developers
IBM stock gained after it introduced Quantum Nighthawk, a new 120-qubit processor that marks its most advanced quantum chip so far.
Market Analysis
Santa Claus Rally: 3 Discounted Stocks Heading into 2026
Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.
Earnings
Legend Biotech (LEGN) Shows Strong Q3 Performance Despite Revenue Shortfall
Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.
Earnings
GlobalFoundries (GFS) Tops Q3 Estimates and Lifts Q4 2025 Outlook
GlobalFoundries (GFS) topped Q3 2025 expectations with $1.688 billion in revenue and $0.44 EPS and issued optimistic guidance for the next quarter.